Cargando…
The γ-Adducin 1–357 fragment promotes tau pathology
BACKGROUND: Tau phosphorylation is a pathological hallmark of Alzheimer’s disease (AD). Previously, we reported that the γ-adducin 1–357 fragment is present in the brains of AD patients. However, it remains unknown how γ-adducin regulates tau phosphorylation. OBJECTIVE: The aim of this project is to...
Autores principales: | Yu, Honglu, Xiong, Min, Liu, Congcong, Xia, Danhao, Meng, Lanxia, Zhang, Zhentao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526357/ https://www.ncbi.nlm.nih.gov/pubmed/37771520 http://dx.doi.org/10.3389/fnagi.2023.1241750 |
Ejemplares similares
-
Silica Nanoparticles Promote α-Synuclein Aggregation and Parkinson’s Disease Pathology
por: Yuan, Xin, et al.
Publicado: (2022) -
Time-dependent alterations in the rat nigrostriatal system after intrastriatal injection of fibrils formed by α–Syn and tau fragments
por: Yang, Xiaoman, et al.
Publicado: (2022) -
Transgenic Mice Expressing Human α-Synuclein 1-103 Fragment as a Novel Model of Parkinson’s Disease
por: Tian, Ye, et al.
Publicado: (2021) -
Islet amyloid polypeptide cross-seeds tau and drives the neurofibrillary pathology in Alzheimer’s disease
por: Zhang, Guoxin, et al.
Publicado: (2022) -
The yeast prion protein Sup35 initiates α-synuclein pathology in mouse models of Parkinson’s disease
por: Meng, Lanxia, et al.
Publicado: (2023)